BAYHEALTH HOSPITAL KENT CAMPUS
1. Target Overview & Investment Thesis
BAYHEALTH HOSPITAL KENT CAMPUS is a 279-bed suburban community hospital in KENT, DE with $588.4M in net patient revenue and a -7.6% operating margin. The hospital serves a payer mix of 34.5% Medicare, 6.8% Medicaid, and 58.7% commercial.
Thesis: Undervalued. Our ML models identify $43.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.6% to -0.2% (+736bps).
| Net Revenue HCRIS | $588.4M |
| Current EBITDA COMPUTED | $-44.6M |
| Operating Margin COMPUTED | -7.6% |
| Occupancy HCRIS | 76.1% |
| Revenue / Bed COMPUTED | $2.1M |
| Net-to-Gross HCRIS | 35.5% |
| Distress Probability ML | 43.0% |
2. Market Context & Competitive Position
DE has 14 Medicare-certified hospitals with a median operating margin of 0.7%. The target's margin of -7.6% places it below the state median. Among 1579 size-comparable peers (140-558 beds), the median margin is -3.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (140-558), prioritizing same-state peers. 1579 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BAYHEALTH HOSPITAL KENT CAMPU (Target) | DE | 279 | $588.4M | -7.6% |
| MEMORIAL HOSPITAL FOR CANCER A | NY | 514 | $4.34B | -32.5% |
| RONALD REAGAN UCLA | CA | 446 | $2.62B | -6.8% |
| OHSU HOSPITAL AND CLINICS | OR | 549 | $2.57B | -6.3% |
| LUCILE PACKARD CHILDRENS HOSPI | CA | 394 | $2.39B | -0.8% |
| UNIVERSITY OF MIAMI HOSP & CLI | FL | 532 | $2.36B | 0.9% |
| MAYO CLINIC HOSPITAL | AZ | 315 | $2.25B | 1.4% |
| RAINBOW BABIES & CHILDRENS HOS | OH | 231 | $2.22B | -5.0% |
| EASTERN MAINE MEDICAL CENTER | ME | 352 | $2.05B | 48.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $43.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $12.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $11.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $11.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $7.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $377K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-44.6M |
| + RCM Uplift | +$43.3M |
| Pro Forma EBITDA | $-1.2M |
| Current Margin | -7.6% |
| Pro Forma Margin | -0.2% |
| WC Released (1x) | $22.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-68.5M | $139.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-68.5M | $130.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-61.7M | $251.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-61.7M | $256.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-75.4M | $-55.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-75.4M | $-85.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 1579 hospitals with 140-558 beds
- Same-state prioritization (n=5)
- Comp margins: P25=-13.5% / P50=-3.9% / P75=5.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.